DoD Autism Resource Development Award
Sector: Hospital • Location: United States of America
Source: Grants.gov
The ARP Resource Development Award mechanism is being offered for the first time in FY10. The ARP recognizes the critical need for improved resources to advance the field of ASD research and diagnosis, and to improve outcomes for individuals with ASD. The Resource Development Award supports product-driven research aimed at developing tools for use by the ASD research and/or clinical communities.
Project Information FAQ
Project Information
Want to explore the full details? View the full report
Participants
Sponsoring Agency | Obfuscated Data |
Company | Obfuscated Data |
Status
Original status | archived |
Taiyo status | Obfuscated Data |
Taiyo last update | 00-00-0000 |
Available timestamps | 00-00-0000 |
Available timestamp type | Obfuscated Data |
Contact
Contact name | Obfuscated Data |
Phone | 0000000000 |
ObfuscatedData@email.com | |
Address | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Description
Description | The ARP Resource Development Award mechanism is being offered for the first time in FY10. The ARP recognizes the critical need for improved resources to advance the field of ASD research and diagnosis, and to improve outcomes for individuals with ASD. The Resource Development Award supports product-driven research aimed at developing tools for use by the ASD research and/or clinical communities. These resources may include, but are not limited to, high-throughput assays, non-invasive imaging techniques, diagnostic tests, databases, devices, clinical tools, and model systems. Applicants should clearly articulate how the proposed product addresses an unmet need in the ASD research or clinical communities. Research involving human subject use is permitted under this funding opportunity, but is restricted to studies without Clinical Trials. In general, a clinical trial is defined as a prospective study where an intervention (e.g., device, drug, behavioral, surgical procedure, or other) is tested on human subjects for a measurable outcome. Principal Investigators (PIs) wishing to apply for funding for a clinical trial should utilize the Clinical Trial Award mechanism. Refer to the General Application Instructions, Appendix 5, for additional information about studies involving human subjects, human subjects data, or human anatomical substances. Preliminary data relevant to the proposed product development is allowed, but not required. Preliminary data, unpublished results from the laboratory of the PI, research team, or collaborators named on this application, may be from outside of the ASD research field. Proposals should be based on a sound scientific rationale that is established through logical reasoning and critical review and analysis of the literature. Resource Distribution Plan: A plan describing the means by which the fully developed resource will be made available to the scientific and/or clinical community at reasonable or appropriate administrative costs, such as costs required for packaging and shipping the resource, should be addressed in the application. |
Original sub-sector | Obfuscated |
Original Currency | USD |
Original budget | 000000000000000 |
Procurement method | Obfuscated Data |
Budget | 000000000000000 |
Location
Region | Obfuscated |
Country | Obfuscated |
State | Obfuscated Data |
County | Obfuscated |
Location | Obfuscated Data, Obfuscated data, obfuscated data, Obfuscated data |
Source
Source reliability | High |
Data quality score | 100% |
Source | Obfuscated Data |
URL | obfuscated_data,obfuscateddata.com |
More Details
Project Type | Obfuscated Data |
Article Published Date | Obfuscated Data |
